Carboxypenicillins: Structural Features and Spectrum
These are broad-spectrum antibiotics that are less potent than aminopenicillins against most organisms. Their key chemical feature is the presence of a carboxyl group in the side chain.
This structure gives the molecules a negative charge, providing stability against certain chromosomal bacterial β-lactamases. However, due to the lack of an amino group, the antibiotic molecules diffuse poorly through the porin channels of Gram-negative bacteria. Consequently, high doses are required to achieve effective intracellular concentrations.
Spectrum of Activity:
- Susceptible: Many members of the family Enterobacteriaceae, as well as Pseudomonas and Enterobacter.
- Resistant (spectrum gaps): Klebsiella spp., Proteus vulgaris, C. diversus, Enterococcus faecalis.
Characteristics of Carboxypenicillins
The primary indication for these drugs is infections caused by Pseudomonas aeruginosa.
- Carbenicillin
A derivative of 6-aminopenicillanic acid. It is acid-labile, poorly absorbed in the gastrointestinal tract, and therefore administered exclusively parenterally (intramuscularly or intravenously) 4–6 times daily. It does not cross the blood-brain barrier (BBB), is approximately 50% plasma protein-bound, and is eliminated predominantly by the kidneys. It is inactivated by β-lactamases.
In addition to typical penicillin hypersensitivity reactions (anaphylactic shock, urticaria, angioedema), carbenicillin has specific toxic effects:
- Hypernatremia: The drug is formulated as a disodium salt, creating an excess sodium load and increasing the risk of exacerbating heart failure.
- Hypokalemia: In the distal renal tubules, potassium cations are excreted alongside the poorly reabsorbable antibiotic anion.
- Bleeding diathesis: Caused by impaired platelet aggregation.
- Carfecillin
A phenyl ester of carbenicillin. Its main advantage is acid stability and good gastrointestinal absorption, allowing for oral administration 3 times daily.
- Ticarcillin
More potent than carbenicillin, especially against Pseudomonas aeruginosa. Like carbenicillin, it is poorly absorbed orally and must be administered parenterally 4–6 times daily.
Ureidopenicillins
This group includes azlocillin, piperacillin, and mezlocillin.
Their spectrum of activity is largely similar to carboxypenicillins, but they offer several important advantages:
- 4- to 8-fold greater activity against Pseudomonas aeruginosa.
- Higher activity against Klebsiella and Gram-positive flora.
Like carboxypenicillins, they are degraded by staphylococcal and Gram-negative β-lactamases and must be administered parenterally.
Clinical Applications and Comparative Potency
Both groups share a primary clinical utility: the ability to eradicate Pseudomonas aeruginosa. Target pathogens also include Proteus and E. coli.
Main Indications:
- Sepsis
- Wound infections
- Pneumonia
- Urinary tract infections
- Intra-abdominal and pelvic infections
Ranking of Antipseudomonal Activity (in descending order):
- Azlocillin and Piperacillin (highest activity)
- Mezlocillin and Ticarcillin (moderate activity)
- Carbenicillin (lowest activity in the group)